RENOVARO INC. - COMMON STOCK

Statement of Renovaro Inc

14 2 2024 10:01:30 提供 Nasdaq GlobeNewswire

Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace

13 2 2024 09:46:07 提供 Nasdaq GlobeNewswire

AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine

13 2 2024 09:31:09 提供 Nasdaq GlobeNewswire

Renovaro Biosciences Announces Results of Special Meeting of Shareholders

25 1 2024 12:45:00 提供 Nasdaq GlobeNewswire

Message from Renovaro Bioscience, Inc.’s CEO, The Hon. Mark Dybul, MD

16 1 2024 08:00:00 提供 Nasdaq GlobeNewswire

Avram Miller, Co-Founder of Intel Capital, Joins Renovaro Biosciences Board of Directors

11 10 2023 09:25:00 提供 Nasdaq GlobeNewswire

Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors

10 10 2023 08:00:00 提供 Nasdaq GlobeNewswire

Message from Renovaro Biosciences CEO, The Hon. Mark Dybul, MD

02 10 2023 12:05:40 提供 Nasdaq GlobeNewswire

AI Company GEDiCube and Renovaro Biosciences Sign Definitive Agreement to Combine

02 10 2023 09:25:00 提供 Nasdaq GlobeNewswire

Renovaro Biosciences and AI Health Company GEDi Cube Sign Definitive Agreement to Combine

29 9 2023 09:15:00 提供 Nasdaq GlobeNewswire

Renovaro BioSciences Welcomes GEDiCube Announcement of New Joint Effort

30 8 2023 09:15:00 提供 Nasdaq GlobeNewswire

Renovaro BioSciences Congratulates GEDi Cube on Appointment of its Chief Medical Officer

21 8 2023 09:15:00 提供 Nasdaq GlobeNewswire

AI Company GEDi Cube and Renovaro Biosciences Announce a Binding, Exclusive Letter of Intent to Merge, Accelerating Fight Against Cancer

09 8 2023 09:00:00 提供 Nasdaq GlobeNewswire

Enochian BioSciences Inc. Announces Adjournment of 2023 Annual Stockholder Meeting

23 6 2023 17:00:00 提供 Nasdaq GlobeNewswire

Enochian BioSciences Announces that its Cancer Platform Remains on Track for Trials in Humans Following FDA Review

08 6 2023 08:45:00 提供 Nasdaq GlobeNewswire

Enochian BioSciences’ CEO Letter to Shareholders

03 4 2023 09:00:00 提供 Nasdaq GlobeNewswire

Enochian BioSciences Announces a Scientific Presentation of Proof-of-Concept Studies for a Potential Therapy for Cancers with a Poor Life Expectancy by a Leading Researcher

29 3 2023 09:00:00 提供 Nasdaq GlobeNewswire

Enochian BioSciences Achieves Full Compliance with NASDAQ Filing Requirements

13 3 2023 08:30:00 提供 Nasdaq GlobeNewswire

Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended December 31, 2022

23 2 2023 16:04:00 提供 Nasdaq GlobeNewswire

Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended September 30, 2022

30 11 2022 17:20:12 提供 Nasdaq GlobeNewswire